Home » Topics » Regulatory » Patents

Patents
RSS

Genentech and Roche describe NMDA receptor modulators

Nov. 7, 2016

Jiangsu Hengrui Medicine discloses IDO1 and/or TDO inhibitors

Nov. 7, 2016

Ruijin Hospital, Brandeis University and Xiamen University patent protein kinase inhibitors

Nov. 7, 2016

Merck KGaA presents novel activin receptor-like kinase inhibitors

Nov. 4, 2016

FORMA Therapeutics discovers new histone deacetylase inhibitors

Nov. 4, 2016

Galapagos describes novel GPR84 antagonists

Nov. 4, 2016

SIMM reports development of mGlu5 receptor modulators

Nov. 3, 2016

FORMA Therapeutics patents HDAC inhibitors

Nov. 3, 2016

AbbVie presents TNF-alpha modulators

Nov. 3, 2016

IURTC presents anti-HBV agents

Nov. 2, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...